The objectives of the study were to assess the thyroid status of pregnant women by estimating serum thyroid stimulating hormone (TSH), serum free triiodothyronine (FT 3 ) and free thyroxine (FT 4 ).Also to find out the association between status of thyroid function with socio-demographic and obstetric characteristics.
Material and methods:
This cross-sectional study was done in the department of Obstetrics and Gynaecology on 230 pregnant women in collaboration with the departments of Endocrinology, Biochemistry, Pathology and Center for Nuclear Medicine and Ultrasound, Dhaka Medical College and Hospital, Dhaka from July 2011 to June 2012. Pregnant women attending at antenatal clinic in the 1 st half of pregnancy were the study population. Where, inclusion criteria were healthy singleton pregnant women up to 20 weeks of gestation. On the other hand the exclusion criteria's were pregnancy with known maternal thyroid disease, suffering from acute febrile illness, chronic disease such as hypertension, diabetes mellitus and renal disease, family history of thyroid disease, patients taking drugs that interfere with thyroid function like lithium, amioderone, steroids, carbamazepine, dopamine and salicylates,women with a history of miscarriage, obese and had other autoimmune disorder. The basis of exclusion criteria was as characterized by American Thyroid Association. 5, 9, 13 All the subjects were purposively selected.
Estimation carried out by ADIVA Centaur CP and Radioimmunoassay. Thyroid disorders of pregnant women were diagnosed based on trimester specific serum TSH reference intervals considered from the recommendation of American Thyroid Association Guideline in 2011, where pregnant women with serum TSH ranging from 0.1 to 2.5 mIU/L in 1 st trimester and 0.2 -3.0 mIU/L in the 2 nd trimester were taken as normal rage. 5, 9 Tietz pregnancy specific reference values for Free Thyroxine (FT 4 ) in first trimester 9.0 to 25.7 pmol/L and in second trimester 6.4 to 20.6 pmol/L. 14 Although, in our laboratory trimester specific reference ranges were not available and only adult values were present as serum TSH (0.35-5.5 mIU/L), serum FT 3 (2.80-9.50 pmol/L) and serum FT 4 (9.50-25.50 pmol/L) respectively. The test statistics used to analyze the data were Chi-square (÷ 2 ) test and unpaired Student's t-test with its 95% confidence interval (CI). For all analytical tests, the level of significance was set at 0.05 and p < 0.05 was considered significant. Ethical clearance was obtained from appropriate authority. Privacy and confidentiality were strictly maintained.
Results:
The mean serum TSH level in first half of pregnancy was 1.63 ± 0.91 mIU/L (range = 0.05 -4.72 mIU/L), while serum FT 3 and FT 4 levels were 3.4 ± 0.4 and 18.6 ± 3.1 pmol/L (range: 2.92 -4.50 and 12.9 -25.7 pmol/L respectively) ( Table I) . Thyroid function status based on serum level of TSH shows that 13% of the patients were subclinical hypothyroid, 3% were subclinical hyperthyroid and the rest (84%) were euthyroid. Thus, a total of 37(16%) pregnant women had abnormal thyroid function status (Table II) . Table III shows the demographic characteristics of healthy singleton pregnant women up to 20 weeks of gestation where, over 30% of the patients were below 20 years, 62.6% between 20 -25 years and 7% of the patients were >25 years old. The mean age of the patients was 24.1 ± 4.5 years. The study subjects were predominantly house-wife (91.3%). Majority (88.7%) of women were educated. The mean Body Mass Index (BMI) of the study subjects was 22.1± 4.4 (kg/m 2 ). Thyroid function status according to obstetric characteristics is shown in Table IV. In the 1 st trimester 11.5% were subclinical hypothyroid, 84.4% were euthyroid and 4.1% were subclinical hyperthyroid and in the 1 st half of 2 nd trimester (13-20wks) 14.8% were subclinical hypothyroid, 83.3% euthyroid and only 1.9% subclinical hyperthyroid. Multigravida were more frequently subclinical hypothyroid (14.9%) than the primigravida (9.5%). No significant difference was observed between thyroid function and obstetric characteristics of the women (in terms of gestational age and gravidity) (p = 0.485 and p = 0.518 respectively). Table V shows the association between age and thyroid function status. Over 45% of women with abnormal thyroid status were older than 24 years as compared to 31.6% of euthyroid women (p = 0.091) ( Table V) .
The women with abnormal thyroid status were comparatively older than the women with euthyroid status, although the difference did not reach the level of significance (p = 0.061) ( Table V) . 
Discussion:
Thyroid diseases in pregnancy can affect the health of the mother as well as the child. If has adverse effects on foetal and maternal well being and can extend beyond pregnancy and delivery to affect neuro intellectual development in the early life of child. So it needs to be evaluation. Based on normal range of serum TSH in the 1 st and 1 st half of 2 nd trimesters (13-20 weeks) of pregnancy, 13% of the women were subclinically hypothyroid and 3% were subclinically hyperthyroid yielding a total of 16% pregnant women with abnormal thyroid function status. In a study in Poland, 10.4% of the pregnant women screened for thyroid dysfunction in their 1 st trimester exhibited (hypothyroidism), which is quite close to this study findings (13% hypothyroidism). 16 In a similar study conducted by Begum in Bangladesh where,clinical and subclinical hypothyroidism together comprised 8% of the pregnant women and clinical and subclinical hyperthyroidism together formed 7.5% thus constituting a total 15.5% with abnormal thyroid function which compares well with the findings of the present study. 17 According to Klein in contrast to hyperthyroidism, hypothyroidism is quite common in pregnancy, which correlated with this study where subclinical hypothyroidism was 13% in comparison to subclinical hyperthyroidism(3%). 18 However, Spong in a study of screening for subclinical hypothyroidism in pregnant women demonstrated a much lower proportion of hypothyroid status (1 in 40 antenatal mothers screened). 19 Besides, there was slight but significant ethnic differences in serum TSH concentrations, which should also be taken into account while screening for thyroid hormones in pregnant women. 13, 20 Black and Asian women have TSH values that are on average 0.4 mIU/ L lower than in white women; these differences persist during pregnancy. 20, 21, 22 Pregnant women of Moroccan, Turkish, or Surinamese descent residing in the Netherlands, have TSH values 0.2-0.3 mIU/L lower than Dutch women throughout pregnancy. 21 Kumar and associates found that mean T 4 levels began to rise from 16.45 pmol/L in the first trimester to 16.58 pmol/L in the second trimester and then decreased in the third trimester to 15.99 pmol/L, they also reported that mean TSH level also rise progressively through the three trimesters of pregnancy from 1.20 mlU/ L in the first trimester to 2.12 mIU/L in the second trimester and further to 3.30 mIU/L in the third trimester of pregnancy, which was not consistent with this study findings. 22 We did not observe the levels of thyroid hormones in each trimester of pregnancy. Some pregnant women attended at first and some at part of 2nd trimester of pregnancy and their mean levels of FT 3 , FT 4 and TSH were 3.4 ± 0.4 pmol/L,18.6 ± 3.1 pmol/L and 1.63 ± 0.91 mIU/L respectively. Therefore, reference range of TSH values significantly overlaps those of the non pregnant state. So trimesters specific hormone level is mandatory to categorize the patient during pregnancy.
In the study most (63%) of the patients were in their 2 nd decades of life with mean age 24 years (range: 16 -37 years), there was no association between age and thyroid function alteration. A similar Iranian study conducted on pregnant women of 16-40 years old, however, demonstrated no significant change in serum TSH level in any of the three trimesters of pregnancy compared to their non-pregnant counterparts. 11 In this study neither gravidity of women nor their gestational age was found to be associated with their thyroid function status. While an Indian study reported no variations in serum TSH and serum FT 3 between trimesters, but there is a significant variation in FT 4 between trimesters with values decreasing with advancing gestational age. 23 From the findings of the study it is evident that thyroid disorder is more or less common in the first half of pregnancy. However, none of the demographic or obstetric characteristics were found to influence thyroid function significantly. Hypothyroidism is more common than the hyperthyroidism.
Limitation of the study was that it was conducted on a small sample size, which lacks generalization of the findings to reference population; the study did not investigate the thyroid function status in the last half of pregnancy and its effect on the fetus or the mother. In-spite of detecting abnormal thyroid function no treatment was given and outcome of babies were not followed up as it is a preliminary report of only screening. As this report shows the presence of abnormal thyroid function a large multicenter controlled study can be conducted to rule out abnormal thyroid function and necessities of treatment to avoid probable adverse effect on mother and foetus.
Conclusion:
From the findings of the study and discussion thereof it can be concluded that one in every six women may have thyroid disorder (primarily hypothyroidism) in the first half of pregnancy. None of the demographic and obstetric characteristics plays any role in the development of abnormality in thyroid function. Subclinical hypothyroidism is far more common than the subclinical hyperthyroidism. The proportion of subclinical thyroid dysfunction (both hypo-& hyperthyroidism) is no less and frequently remains undiagnosed, unless specific screening program is initiated to disclose thyroid function abnormalities in early gestation. So, if feasible routine screening at least serum TSH level can be done in all pregnant women attending antenatal visit.
